Inventor · disambiguated record
Jiawang Zhu
Also filed as: ZHU JIAWANG
17 granted patents·7 pending applications·79 citations·filing 2003–2022
92Inventor score
Files withAMGEN INC16SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD3ARRAY BIOPHARMA INC1BISWAS KAUSTAV1CHEN JIAN J1
Top patents by PatentIndex Score
24 records- 0191US7579347B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Aug 25, 2009·17 cites·9 claims
- 0285US7989461B2Substituted quinazolinamine compounds for the treatment of cancerAMGEN INC·Filed 2006·Granted Aug 2, 2011·9 cites·14 claims
- 0384US7053088B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2003·Granted May 30, 2006·19 cites·22 claims
- 0482US7396831B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Jul 8, 2008·5 cites·21 claims
- 0582US7335672B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Feb 26, 2008·6 cites·12 claims
- 0678US7544803B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Jun 9, 2009·3 cites·4 claims
- 0777US7144888B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2003·Granted Dec 5, 2006·9 cites·25 claims
- 0873US8440674B2Substituted pyrimidine compounds as RAF inhibitors and methods of useDE MORIN FRENEL F·Filed 2011·Granted May 14, 2013·4 cites·12 claims
- 0972US7148221B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Dec 12, 2006·1 cites·19 claims
- 1070US7662811B21,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of useAMGEN INC·Filed 2005·Granted Feb 16, 2010·1 cites·13 claims
- 1167US7393852B2Piperazine derivatives and methods of useAMGEN INC·Filed 2004·Granted Jul 1, 2008·3 cites·42 claims
- 1264US7199244B2Cyclic amine derivatives and methods of useARRAY BIOPHARMA INC·Filed 2004·Granted Apr 3, 2007·2 cites·48 claims
- 1364US2009264424A1Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2009·Application pending·0 cites
- 1459US2024254082A1Substituted Isoindoline-1, 3-diketone PDE4 Inhibitor and Pharmaceutical Application ThereofSUZHOU INTRAGRAND PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 1556US11261170B2Aromatic compound, pharmaceutical composition and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2020·Granted Mar 1, 2022·0 cites·32 claims
- 1654US7524874B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Apr 28, 2009·0 cites·19 claims
- 1754US7332511B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Feb 19, 2008·0 cites·19 claims
- 1854US2009054460A1Piperazine derivatives and methods of useCHEN JIAN J·Filed 2008·Application pending·0 cites
- 1952US2011166132A1Gamma Secretase ModulatorsAMGEN INC·Filed 2008·Application pending·0 cites
- 2051US2011118234A1Urea Compounds as Gamma Secretase ModulatorsBISWAS KAUSTAV·Filed 2009·Application pending·0 cites
- 2148US11332457B2Aromatic compound, pharmaceutical composition and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2018·Granted May 17, 2022·0 cites·31 claims
- 2245US2009227601A1Bradykinin 1 Receptor AntagonistsAMGEN INC·Filed 2006·Application pending·0 cites
- 2338US7553848B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Jun 30, 2009·0 cites·18 claims
- 2438US2020087248A1Fluoroallylamine Derivative And Use ThereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →